Primary thromboembolism prophylaxis in outpatient cancer patients receiving chemotherapy

被引:0
|
作者
Draeger, Desiree L. [1 ,2 ]
机构
[1] Univ Med Rostock, Klin & Poliklin Urol, Schillingallee 35, D-18057 Rostock, Germany
[2] Deutsch Gesell Urol, UroEvidence DGU, Berlin, Germany
来源
UROLOGIE | 2024年
关键词
VENOUS THROMBOEMBOLISM; PREVENTION;
D O I
10.1007/s00120-024-02273-y
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [41] Venous thromboembolism and prophylaxis in cancer patients
    Paskauskas, Saulius
    Pundzius, Juozas
    Barauskas, Giedrius
    MEDICINA-LITHUANIA, 2008, 44 (03): : 175 - 181
  • [42] Relation between fatigue and quality of life in cancer patients receiving outpatient chemotherapy
    Ipek, F.
    Kabak, V. Yildiz
    Uysal, S. Atasavun
    Duger, T.
    LEUKEMIA RESEARCH, 2019, 85 : S22 - S22
  • [43] Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy
    Ting, Yeoh Ting
    Yin, Tay Xin
    Si, Phebe
    Chew, Lita
    JOURNAL OF GERIATRIC ONCOLOGY, 2015, 6 (04) : 280 - 287
  • [44] The Experience of a Sore Mouth and Associated Symptoms in Patients With Cancer Receiving Outpatient Chemotherapy
    Brown, Carlton G.
    McGuire, Deborah B.
    Peterson, Douglas E.
    Beck, Susan L.
    Dudley, William N.
    Mooney, Kathleen H.
    CANCER NURSING, 2009, 32 (04) : 259 - 270
  • [45] SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy
    Garcia Gomez, Jesus
    Perez Lopez, M. Eva
    Garcia Mata, Jesus
    Isla Casado, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (11): : 770 - 774
  • [46] SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy
    Jesús García Gómez
    M. Eva Pérez López
    Jesús García Mata
    Dolores Isla Casado
    Clinical and Translational Oncology, 2010, 12 : 770 - 774
  • [47] Primary prophylaxis of venous thromboembolism in ambulatory cancer patients treated with antineoplastic agents
    Debourdeau, P.
    Simonin, C.
    Carbasse, C.
    Debourdeau, T.
    Zammit, C.
    Scotte, F.
    REVUE DE MEDECINE INTERNE, 2019, 40 (08): : 523 - 532
  • [48] Low-Molecular Weight Heparin Prophylaxis Should Not Be Recommended Even in Highly Selected Patients With Solid Cancer Receiving Outpatient Chemotherapy
    Oo, Thein Hlaing
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4380 - 4381
  • [49] Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer
    McLaughlin, Hannah D.
    Greco, Patricia
    Straubhar, Alli M.
    Rolston, Aimee
    McCool, Kevin
    Brackmann, Melissa
    Siedel, Jean H.
    McLean, Karen
    Reynolds, R. Kevin
    Uppal, Shitanshu
    GYNECOLOGIC ONCOLOGY, 2023, 178 : 89 - 95
  • [50] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
    Fernandes, Ricardo
    Mazzarello, Sasha
    Stober, Carol
    Vandermeer, Lisa
    Dudani, Shaan
    Ibrahim, Mohamed F. K.
    Majeed, Habeeb
    Perdrizet, Kirstin
    Shorr, Risa
    Hutton, Brian
    Fergusson, Dean
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 1 - 10